Swift Biosciences is a fast-moving company focused on developing enabling technologies and products for genomics and personalized medicine. Its technologies provide customers with powerful new methods to examine disease-related genes.
Lophius Biosciences is a biotech company focusing on the development of innovative T cell-based research tools and diagnostic systems for functional assessment of disease-reactive T cells.
Biocartis is a biotech company delivering innovative solutions to the pharmaceutical and healthcare market. Biocartis provides highly automated instruments in combination with novel and broadly applicable molecular diagnostic assays, thus facilitating personalized molecular testing.
PamGene is a biotech company specialized in kinase and nuclear receptor assays for personalized medicine and drug discovery.
OncoDNA is the first European company to provide personalized medicine in oncology based on the analysis of patient tumor DNA.
Affymetrix is a leader in genomic analysis, helping researchers to identify biomarkers for personalized medicine, to create novel molecular diagnostic tests, etc…
Among advances in the field of genomic, single-nucleotide polymorphism (SNP) research has attracted a lot of attentions in recent years. SNP genotyping serves as the technological basis to understand the causes of diseases at the genetic level, and is very useful for pharmacogenomic researchers. In order to establish a certain path to the realization of personalized medicine, Riken Genesis is using state-of-the-art technology to explore a total of 6 billion base pairs.
